In the ST-treated group, we observed increased Bcl-2 expression at 3 and 6 h (p = 0.0088 and p < 0.0001, respectively, compared with the vehicle control), but mRNA levels in the treated rats were lower compared with vehicle rats at 6, 16, and 24 h after stroke (p = 0.0416, p < 0.0001, and p < 0.0001, respectively). This evidence concerns the gene BCL2 and stroke disorder.